Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001688522-26-000006·Philotimo Fund, LP
Schedule 13G ownership disclosure
APYX MEDICAL CORPORATION
Common Stock, $0.001 par value per share · CUSIP: 03837C106
Event date: 2026-10-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Philotimo Fund, LP
Shares: 1,425,473.00 · Class: 3.4%
- Philotimo Focused Growth & Income Fund
Shares: 855,045.00 · Class: 2.0%
- Kanen Wealth Management LLC
Shares: 2,280,518.00 · Class: 5.4%
- Kanen David
Shares: 2,280,518.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001688522-26-000006
- Form type
- SCHEDULE 13G
- Filer
- Philotimo Fund, LP
- CIK
- CIK 1688522
- Filed
- Oct 28, 2026
- Reporting period
- Oct 21, 2026
- Description
- Schedule 13G beneficial ownership